These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 12370832)

  • 1. Mdm-2 binding and TAF(II)31 recruitment is regulated by hydrogen bond disruption between the p53 residues Thr18 and Asp21.
    Jabbur JR; Tabor AD; Cheng X; Wang H; Uesugi M; Lozano G; Zhang W
    Oncogene; 2002 Oct; 21(46):7100-13. PubMed ID: 12370832
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DNA damage-induced phosphorylation of p53 at serine 20 correlates with p21 and Mdm-2 induction in vivo.
    Jabbur JR; Huang P; Zhang W
    Oncogene; 2000 Dec; 19(54):6203-8. PubMed ID: 11175334
    [TBL] [Abstract][Full Text] [Related]  

  • 3. p53 Antiproliferative function is enhanced by aspartate substitution at threonine 18 and serine 20.
    Jabbur JR; Zhang W
    Cancer Biol Ther; 2002; 1(3):277-83. PubMed ID: 12432277
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modulation of the p53-MDM2 interaction by phosphorylation of Thr18: a computational study.
    Lee HJ; Srinivasan D; Coomber D; Lane DP; Verma CS
    Cell Cycle; 2007 Nov; 6(21):2604-11. PubMed ID: 17957142
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The alpha-helical FXXPhiPhi motif in p53: TAF interaction and discrimination by MDM2.
    Uesugi M; Verdine GL
    Proc Natl Acad Sci U S A; 1999 Dec; 96(26):14801-6. PubMed ID: 10611293
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhancement of the antiproliferative function of p53 by phosphorylation at serine 20: an inference from site-directed mutagenesis studies.
    Jabbur JR; Huang P; Zhang W
    Int J Mol Med; 2001 Feb; 7(2):163-8. PubMed ID: 11172619
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Defect in the p53-Mdm2 autoregulatory loop resulting from inactivation of TAF(II)250 in cell cycle mutant tsBN462 cells.
    Wasylyk C; Wasylyk B
    Mol Cell Biol; 2000 Aug; 20(15):5554-70. PubMed ID: 10891494
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stabilization and activation of p53 by the coactivator protein TAFII31.
    Buschmann T; Lin Y; Aithmitti N; Fuchs SY; Lu H; Resnick-Silverman L; Manfredi JJ; Ronai Z; Wu X
    J Biol Chem; 2001 Apr; 276(17):13852-7. PubMed ID: 11278372
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The regulation of p53-mediated transcription and the roles of hTAFII31 and mdm-2.
    Lu H; Lin J; Chen J; Levine AJ
    Harvey Lect; 1994-1995; 90():81-93. PubMed ID: 8803320
    [No Abstract]   [Full Text] [Related]  

  • 10. An abnormality in the p53 pathway following gamma-irradiation in many wild-type p53 human melanoma lines.
    Bae I; Smith ML; Sheikh MS; Zhan Q; Scudiero DA; Friend SH; O'Connor PM; Fornace AJ
    Cancer Res; 1996 Feb; 56(4):840-7. PubMed ID: 8631022
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationships between G1 arrest and stability of the p53 and p21Cip1/Waf1 proteins following gamma-irradiation of human lymphoma cells.
    Bae I; Fan S; Bhatia K; Kohn KW; Fornace AJ; O'Connor PM
    Cancer Res; 1995 Jun; 55(11):2387-93. PubMed ID: 7757991
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mdm-2 phosphorylation by DNA-dependent protein kinase prevents interaction with p53.
    Mayo LD; Turchi JJ; Berberich SJ
    Cancer Res; 1997 Nov; 57(22):5013-6. PubMed ID: 9371494
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The carboxy-terminal serine 392 phosphorylation site of human p53 is not required for wild-type activities.
    Fiscella M; Zambrano N; Ullrich SJ; Unger T; Lin D; Cho B; Mercer WE; Anderson CW; Appella E
    Oncogene; 1994 Nov; 9(11):3249-57. PubMed ID: 7936649
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mdm2 inhibition of p53 induces E2F1 transactivation via p21.
    Wunderlich M; Berberich SJ
    Oncogene; 2002 Jun; 21(28):4414-21. PubMed ID: 12080472
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The human vaccinia-related kinase 1 (VRK1) phosphorylates threonine-18 within the mdm-2 binding site of the p53 tumour suppressor protein.
    Lopez-Borges S; Lazo PA
    Oncogene; 2000 Jul; 19(32):3656-64. PubMed ID: 10951572
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phosphorylation of serines 15 and 37 is necessary for efficient accumulation of p53 following irradiation with UV.
    Bean LJ; Stark GR
    Oncogene; 2001 Mar; 20(9):1076-84. PubMed ID: 11314044
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular pathology of primary and metastatic ductal pancreatic lesions: analyses of mutations and expression of the p53, mdm-2, and p21/WAF-1 genes in sporadic and familial lesions.
    Ruggeri BA; Huang L; Berger D; Chang H; Klein-Szanto AJ; Goodrow T; Wood M; Obara T; Heath CW; Lynch H
    Cancer; 1997 Feb; 79(4):700-16. PubMed ID: 9024708
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predictive value of p53, mdm-2, p21, and mib-1 for chemotherapy response in advanced breast cancer.
    Sjöström J; Blomqvist C; Heikkilä P; Boguslawski KV; Räisänen-Sokolowski A; Bengtsson NO; Mjaaland I; Malmström P; Ostenstadt B; Bergh J; Wist E; Valvere V; Saksela E
    Clin Cancer Res; 2000 Aug; 6(8):3103-10. PubMed ID: 10955790
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transition from in situ to invasive testicular germ cell neoplasia is associated with the loss of p21 and gain of mdm-2 expression.
    Datta MW; Macri E; Signoretti S; Renshaw AA; Loda M
    Mod Pathol; 2001 May; 14(5):437-42. PubMed ID: 11353054
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phage-peptide display identifies the interferon-responsive, death-activated protein kinase family as a novel modifier of MDM2 and p21WAF1.
    Burch LR; Scott M; Pohler E; Meek D; Hupp T
    J Mol Biol; 2004 Mar; 337(1):115-28. PubMed ID: 15001356
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.